Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

pertuzumab

pertuzumab
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Perjeta SOLUTION, INTRAVENOUS 420 mg/14 mL      
VIEW MORE Antineoplastic Agents
CLASS
100000
Comments:

Perjeta is formulary, restricted to outpatient oncology.

Reviewed: August 28, 2012, and 27 Nov 2018

Last updated: Jun. 28, 2022






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved